Track Lux Health Tech Acquisition - Warrants(30/11/2027)'s common stock ($690M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (June 2022), LUXAW shows a common stock of $690M. That compares with $310M in the prior-year period — up 126.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, LUXAW's common stock is now $690M (was $310M) — a 126.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Lux Health Tech Acquisition - Warrants(30/11/2027) is outperforming or lagging.
Tracking LUXAW's common stock over time shows whether Lux Health Tech Acquisition - Warrants(30/11/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $690M That compares with $310M in the prior-year period — up 126.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has Lux Health Tech Acquisition - Warrants(30/11/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $690M) with ownership activity and broader fundamentals.